Alan Menter

Featured in: Favicon

sagepub.com Favicon

jamanetwork.com Favicon

thelancet.com Favicon

healio.com Favicon

dermatologytimes.com Favicon

practicaldermatology.com Favicon

jofskin.org Favicon

twill.health Favicon

journals.sagepub.com + 1 more

Articles

Efficacy and safety by body weight decile in patients treated with tildrakizumab 100 mg for 28 weeks: Pooled data analysis of reSURFACE 1 and reSURFACE 2 | SKIN The Journal of Cutaneous Medicine

Mar 13, 2023 | jofskin.org | Alan Menter |Baylor Scott |Zoe D. Draelos |Jayme M Heim

Main Article Content Keywords tildrakizumab, psoriasis, plaque psoriasis, body weight, obesity References 1. Pirro F, et al. Clin Drug Investig. 2021;41(10):917–25. 2.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →